These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 18162604

  • 1. A single amino acid difference between ether-a-go-go- related gene channel subtypes determines differential sensitivity to a small molecule activator.
    Perry M, Sanguinetti MC.
    Mol Pharmacol; 2008 Apr; 73(4):1044-51. PubMed ID: 18162604
    [Abstract] [Full Text] [Related]

  • 2. Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.
    Perry M, Sachse FB, Sanguinetti MC.
    Proc Natl Acad Sci U S A; 2007 Aug 21; 104(34):13827-32. PubMed ID: 17693551
    [Abstract] [Full Text] [Related]

  • 3. C-Linker Accounts for Differential Sensitivity of ERG1 and ERG2 K+ Channels to RPR260243-Induced Slow Deactivation.
    Gardner A, Sanguinetti MC.
    Mol Pharmacol; 2015 Jul 21; 88(1):19-28. PubMed ID: 25888115
    [Abstract] [Full Text] [Related]

  • 4. Concatenated hERG1 tetramers reveal stoichiometry of altered channel gating by RPR-260243.
    Wu W, Gardner A, Sanguinetti MC.
    Mol Pharmacol; 2015 Jul 21; 87(3):401-9. PubMed ID: 25519838
    [Abstract] [Full Text] [Related]

  • 5. PD-118057 contacts the pore helix of hERG1 channels to attenuate inactivation and enhance K+ conductance.
    Perry M, Sachse FB, Abbruzzese J, Sanguinetti MC.
    Proc Natl Acad Sci U S A; 2009 Nov 24; 106(47):20075-80. PubMed ID: 19892732
    [Abstract] [Full Text] [Related]

  • 6. Molecular determinants of human ether-à-go-go-related gene 1 (hERG1) K+ channel activation by NS1643.
    Grunnet M, Abbruzzese J, Sachse FB, Sanguinetti MC.
    Mol Pharmacol; 2011 Jan 24; 79(1):1-9. PubMed ID: 20876384
    [Abstract] [Full Text] [Related]

  • 7. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J, Chen XL, Wang H, Ji J, Cheng H, Incardona J, Reynolds W, Viviani F, Tabart M, Rampe D.
    Mol Pharmacol; 2005 Mar 24; 67(3):827-36. PubMed ID: 15548764
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular Basis of Altered hERG1 Channel Gating Induced by Ginsenoside Rg3.
    Gardner A, Wu W, Thomson S, Zangerl-Plessl EM, Stary-Weinzinger A, Sanguinetti MC.
    Mol Pharmacol; 2017 Oct 24; 92(4):437-450. PubMed ID: 28705808
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ginsenoside Rg3, a Gating Modifier of EAG Family K+ Channels.
    Wu W, Gardner A, Sachse FB, Sanguinetti MC.
    Mol Pharmacol; 2016 Oct 24; 90(4):469-82. PubMed ID: 27502018
    [Abstract] [Full Text] [Related]

  • 14. A highly conserved alanine in the S6 domain of the hERG1 K+ channel is required for normal gating.
    Brown S, Sonntag DP, Sanguinetti MC.
    Cell Physiol Biochem; 2008 Oct 24; 22(5-6):601-10. PubMed ID: 19088442
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular determinants for activation of human ether-à-go-go-related gene 1 potassium channels by 3-nitro-n-(4-phenoxyphenyl) benzamide.
    Garg V, Stary-Weinzinger A, Sachse F, Sanguinetti MC.
    Mol Pharmacol; 2011 Oct 24; 80(4):630-7. PubMed ID: 21743002
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.